Merck and Astellas drugs get priority review in US and Japan

London Stock Exchange
Advanced charts
Premium community
Data download

Get Started

Home
Investing
Stocks
UK
LSE
Merck & Co Inc (0QAH)
Merck & Co Inc (0QAH) News

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Merck & Co Inc	LSE:0QAH	London	Ordinary Share		MERCK & CO ORD (CDI)

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.80	1.80%	102.00	96.80	107.20				23,929	16:35:19

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	60.12B	365M	0.1440	705.83	253.91B

Merck and Astellas drugs get priority review in US and Japan

Merck & Co Inc announced on Tuesday that its cancer treatment Keytruda with chemotherapy has been granted priority re ...

Subscribe now to see this Premium News article from

Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.

Click for a FREE Trial

In The Know - Management and analyst comments that go beyond company announcements.
Flash headlines on all 2,400 London-listed companies before the news hits the open web.
Broker Ratings - The earliest tip-offs, many before the market opens.
Economic data and central bank flashes from UK, US and eurozone.
Taking AIM - Up to the minute market commentary on AIM stocks.
Over 500 news items per trading day for just £39.60 per month, and cancel at any time.

Try Alliance News FREE for 1 Month

Call us on +44 (0) 203 8794 460 to get started.